Mesoridazine besylate 50 mg Oral Tablet
RxNorm 311555
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 311555 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: mesoridazine besylate 50 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Mesoridazine 50 mg Oral Tablet
(Atom ID: 12325524)
SY
Synonym (SY):
Mesoridazine besilate 50 mg oral tablet
(Atom ID: 10806832)
PSN
Prescribable Name (PSN):
Mesoridazine besylate 50 mg Oral Tablet
(Atom ID: 6371958)
PT
Designated preferred name (PT):
Mesoridazine besylate 50 mg oral tablet
(Atom ID: 9251794)
FN
Full form of descriptor (FN):
Product containing precisely mesoridazine besilate 50 mg/1 each conventional release oral tablet (clinical drug)
(Atom ID: 10818943)
Patient Education
Mesoridazine
Mesoridazine is used to treat the symptoms of schizophrenia and reduce restlessness, anxiety, and tension. It can also reduce hyperactivity and uncooperativeness.
[Learn More]
* Please review the disclaimer below.